Event Details
February 25, 2019
Description
Publication of Cowen Collaborative Insights report.
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| Cowen | person | 0 | View Entity |
| Michael Cella | person | 186 | View Entity |
Source Documents (2)
HOUSE_OVERSIGHT_024871.jpg
This document is page 55 of a Cowen financial research report dated February 25, 2019, analyzing the cannabis and CBD market. It details the business models, revenues, and strategies of companies including Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries (Beboe). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely produced as part of a congressional investigation, though no specific Epstein connection is mentioned in the text of this page.
HOUSE_OVERSIGHT_024889.jpg
This document is page 73 of a Cowen financial research report dated February 25, 2019, stamped with a House Oversight Bates number. It details business partnerships in the cannabis/CBD sector, specifically a revenue-sharing agreement between Tilray and Authentic Brands Group (ABG) involving the Nine West brand, and a retail distribution deal between DSW and Green Growth Brands. The document outlines financial terms, including a $100MM-$250MM investment by Tilray, and discusses market expansion opportunities for CBD wellness products.
Related Events
Events with shared participants
Cowen Survey conducted with approximately 2500 participants regarding CBD usage.
2019-01-01 • N/A
Publication of Cowen global cannabis outlook report
2019-01-01 • Global
Consumer Internet Survey conducted throughout the year
2018-01-01 • USA
Publication of Cowen's Collective View of CBD report.
2019-02-25 • N/A
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event